ACR Convergence 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

Spyre Therapeutics at ACR Convergence 2026

Nov 6–11, 2026 Orlando, FL ~15k attendees Website

Spyre Therapeutics brings 2 presentations to ACR Convergence 2026 in Orlando, and exhibits at Booth 2933-CT. Its program centres on TL1A as a target in rheumatoid arthritis, comparing anti-TL1A with anti-TNF in a mouse model and tracing TL1A signaling in the joint lining.

OrganizationACR Convergence 2026 Attendance
Biotech companies
A clinical-stage biotechnology company developing therapies for inflammatory diseases.
Booth
Exhibiting at Booth 2933-CT
Sun, Nov 810:00am–5:00pmMon, Nov 910:00am–5:00pmTue, Nov 1010:00am–2:30pm

Explore the full ACR Convergence 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Orlando. Leave your work email and we’ll be in touch.

Privacy

Download the full ACR Convergence 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Spyre Therapeutics

Tell us what you sell and we’ll find the people at Spyre Therapeutics most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the American College of Rheumatology (ACR). Organization details are derived from the ACR’s published program and exhibitor floor plan, and each organization’s own website. Submit a correction